drugset
drugset / Trial / NCT01494597

Drug Interaction Study of Isavuconazole and Cyclosporine

NCT01494597 ↗

Phase 1 Completed 24 enrolled Astellas Pharma Inc Basilea Pharmaceutica International Ltd · collab
NaSingle-groupOpen-label

Summary

The purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics of cyclosporine in healthy adult subjects.

Timeline

Start
2011-11
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide — Oral
Subject Isavuconazole Small molecule — Oral

Indications

No indication recorded.